Newsfeed The Lead

Covid-19 vaccine: Centre ask all states, UTs to conduct dry run on Jan 2

New Delhi: After conducting a dry run of vaccination in Assam, Andhra Pradesh, Punjab and Gujarat on December 28 and 29, the centre has now planned to extend the drill to rest of the country so that once a vaccine shot is approved for emergency use, administering vaccine goes on without a glitch anywhere. All state capitals will conduct dry runs in at least three session sites on January 2. Some states will also include districts that are situated in difficult terrain or have poor logistical support.

In vaccine dry run, the entire process of transporting the vaccines from storage to the site, administering them to candidates, feeding data on Co-WIN app is practised without any real vaccine. For example, in Gujarat dry run, 475 beneficiaries underwent the dummy procedure, the main aim of which is to identify if there is any loophole in the planned process. Crowd management at a booth, maintaining social distancing guidelines inside the booth are also being practised at the mock drills.

In Gujarat, the dry run was conducted at 19 booths set up in Gandhinagar and Rajkot districts. In Punjab, Ludhiana and Shaheed Bhagat Singh Nagar were selected for the dry run. Nalbari and Sonitpur were the two districts of Assam where the mock drill already took place. Krishna district from Andhra Pradesh was chosen for the two-day drill. Everywhere, the drill went on successfully.

The plan to extend the dry run to all states and UTs comes amid the apex drug regulator body of India indicating that India might start the new year with a vaccine against Covid-19.

“We will have a Happy New Year with something in hand, that’s all I can hint at,” said VG Somani, Drug Controller General of India (DCGI), on Thursday.

The subject expert committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) will meet on January 1 to consider the emergency-use authorisation application of three companies—Pfizer, Serum Institute of India that is to manufacture the Oxford AstraZeneca vaccine, and Bharat Biotech’s Covaxin.

 

Support Ethical Journalism. Support The Dispatch

The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism


 

The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies